117 related articles for article (PubMed ID: 19251765)
1. Post-transcriptional regulation of the expression of ferrochelatase by its variant mRNA.
Sakaino M; Kataoka T; Taketani S
J Biochem; 2009 Jun; 145(6):733-8. PubMed ID: 19251765
[TBL] [Abstract][Full Text] [Related]
2. The influence of sex steroid hormones on ferrochelatase gene expression in Harderian gland of hamster (Mesocricetus auratus).
Vilchis F; Ramos L; Timossi C; Chávez B
J Endocrinol; 2006 Apr; 189(1):103-12. PubMed ID: 16614385
[TBL] [Abstract][Full Text] [Related]
3. Ferrochelatase, glutathione peroxidase and transferrin receptor mRNA synthesis and levels in mouse erythroleukemia cells.
Fuchs O
Stem Cells; 1993 May; 11 Suppl 1():13-23. PubMed ID: 8318915
[TBL] [Abstract][Full Text] [Related]
4. [Ferrochelatase gene expression in erythroid cells].
Fuchs O
Cas Lek Cesk; 1992 Dec; 131(24-25):741-5. PubMed ID: 1288876
[TBL] [Abstract][Full Text] [Related]
5. Regulation of ferrochelatase gene expression by hypoxia.
Liu YL; Ang SO; Weigent DA; Prchal JT; Bloomer JR
Life Sci; 2004 Sep; 75(17):2035-43. PubMed ID: 15312748
[TBL] [Abstract][Full Text] [Related]
6. Hypermethylation of the wild-type ferrochelatase allele is closely associated with severe liver complication in a family with erythropoietic protoporphyria.
Onaga Y; Ido A; Uto H; Hasuike S; Kusumoto K; Moriuchi A; Numata M; Nagata K; Hori T; Hayashi K; Tsubouchi H
Biochem Biophys Res Commun; 2004 Sep; 321(4):851-8. PubMed ID: 15358105
[TBL] [Abstract][Full Text] [Related]
7. Silencing of human ferrochelatase causes abundant protoporphyrin-IX accumulation in colon cancer.
Kemmner W; Wan K; Rüttinger S; Ebert B; Macdonald R; Klamm U; Moesta KT
FASEB J; 2008 Feb; 22(2):500-9. PubMed ID: 17875605
[TBL] [Abstract][Full Text] [Related]
8. Dual mitochondrial localization and different roles of the reversible reaction of mammalian ferrochelatase.
Sakaino M; Ishigaki M; Ohgari Y; Kitajima S; Masaki R; Yamamoto A; Taketani S
FEBS J; 2009 Oct; 276(19):5559-70. PubMed ID: 19691493
[TBL] [Abstract][Full Text] [Related]
9. Late presentation of erythropoietic protoporphyria: case report and genetic analysis of family members.
Berroeta L; Man I; Goudie DR; Whatley SD; Elder GH; Ibbotson SH
Br J Dermatol; 2007 Nov; 157(5):1030-1. PubMed ID: 17711525
[TBL] [Abstract][Full Text] [Related]
10. Biochemical abnormality in erythropoietic protoporphyria: cause and consequences.
Bloomer JR; Wang Y; Singhal A; Risheg H
J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S36-40. PubMed ID: 16819399
[TBL] [Abstract][Full Text] [Related]
11. The effect of haem biosynthesis inhibitors and inducers on intestinal iron absorption and liver haem biosynthetic enzyme activities.
Laftah AH; Simpson RJ; Peters TJ; Raja KB
Toxicol Appl Pharmacol; 2008 Jun; 229(3):273-80. PubMed ID: 18384829
[TBL] [Abstract][Full Text] [Related]
12. Dimethyl sulphoxide and haemin induce ferrochelatase mRNA by different mechanisms in murine erythroleukaemia cells.
Fukuda Y; Fujita H; Taketani S; Sassa S
Br J Haematol; 1993 Mar; 83(3):480-4. PubMed ID: 8485055
[TBL] [Abstract][Full Text] [Related]
13. Porcine ferrochelatase: the relationship between iron-removal reaction and the conversion of heme to Zn-protoporphyrin.
Chau TT; Ishigaki M; Kataoka T; Taketani S
Biosci Biotechnol Biochem; 2010; 74(7):1415-20. PubMed ID: 20622448
[TBL] [Abstract][Full Text] [Related]
14. Heme synthase (ferrochelatase) catalyzes the removal of iron from heme and demetalation of metalloporphyrins.
Taketani S; Ishigaki M; Mizutani A; Uebayashi M; Numata M; Ohgari Y; Kitajima S
Biochemistry; 2007 Dec; 46(51):15054-61. PubMed ID: 18044970
[TBL] [Abstract][Full Text] [Related]
15. The penetrance of dominant erythropoietic protoporphyria is modulated by expression of wildtype FECH.
Gouya L; Puy H; Robreau AM; Bourgeois M; Lamoril J; Da Silva V; Grandchamp B; Deybach JC
Nat Genet; 2002 Jan; 30(1):27-8. PubMed ID: 11753383
[TBL] [Abstract][Full Text] [Related]
16. Ferrochelatase gene mutations in erythropoietic protoporphyria: focus on liver disease.
Chen FP; Risheg H; Liu Y; Bloomer J
Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):83-9. PubMed ID: 11929052
[TBL] [Abstract][Full Text] [Related]
17. Ferrochelatase binds the iron-responsive element present in the erythroid 5-aminolevulinate synthase mRNA.
Ferreira GC
Biochem Biophys Res Commun; 1995 Sep; 214(3):875-8. PubMed ID: 7575558
[TBL] [Abstract][Full Text] [Related]
18. [Expression of transferrin receptor and ferrochelatase mRNAs in MEL cells].
Wang W; Li R; Chen J
Zhonghua Xue Ye Xue Za Zhi; 1999 Jan; 20(1):17-20. PubMed ID: 11498837
[TBL] [Abstract][Full Text] [Related]
19. Novel mutations and phenotypic effect of the splice site modulator IVS3-48C in nine Swedish families with erythropoietic protoporphyria.
Wiman A; Floderus Y; Harper P
J Hum Genet; 2003; 48(2):70-6. PubMed ID: 12601550
[TBL] [Abstract][Full Text] [Related]
20. Iron availability modulates aberrant splicing of ferrochelatase through the iron- and 2-oxoglutarate dependent dioxygenase Jmjd6 and U2AF(65.).
Barman-Aksözen J; Béguin C; Dogar AM; Schneider-Yin X; Minder EI
Blood Cells Mol Dis; 2013 Oct; 51(3):151-61. PubMed ID: 23787363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
